Pharmarise Holdings Corp
Pharmarise Holdings Corp has a liquidity position that is medium, with a current ratio of 1.1 and a debt-to-equity ratio of 2.08, indicating a relatively high leverage position. The company's cash and equivalents amount to 4,911,000,000 JPY, but this is offset by long-term debt of 14,279,000,000 JPY, resulting in a net cash position that is negative after subtracting total debt. Profitability metrics show a return on equity of -6% and a return on assets of -1.29%, both of which are below the industry median for Drug Retailers. The company reported a net loss of 412,000,000 JPY, with an operating income of only 120,000,000 JPY, indicating a weak performance in generating profit from operations. The company's revenue is distributed across five business segments, with the Dispensing Pharmacy segment being the primary source of operations. The Merchandising segment includes cosmetics sales, convenience store management, and drug store management. The Medical Document Storage and Management segment handles the storage of medical records, while the Medical Mall Management segment operates at JR Tower Office Plaza Sapporo. The Others segment includes temporary staffing and stationery sales. Growth trajectory appears to be constrained, with the company reporting a net loss in the latest period. The operating cash flow is 1,313,000,000 JPY, and free cash flow is 142,000,000 JPY, suggesting limited capacity for reinvestment or debt reduction. The capital expenditure of -702,000,000 JPY indicates a reduction in capital spending. Risk factors include a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could impact its ability to meet short-term obligations. The dilution potential is low, with no significant changes in shares outstanding between basic and diluted shares. Recent events include the latest actual EPS of -32.42 JPY and revenue of 63,508,000,000 JPY, as reported by analysts. These figures reflect the company's current financial performance and expectations.
Business. Pharmarise Holdings Corp operates as a Japan-based holding company primarily engaged in dispensing pharmacy businesses, including operations in cosmetics sales, convenience store management, and medical document storage.
Classification. Pharmarise is classified under the Consumer Non-Cyclicals economic sector, Food & Drug Retailing business sector, and Drug Retailers industry with a confidence level of 0.92.
- Pharmarise Holdings Corp is a Japan-based holding company with a primary focus on dispensing pharmacy businesses.
- The company's liquidity position is medium, with a current ratio of 1.1 and a debt-to-equity ratio of 2.08.
- Profitability is weak, with a return on equity of -6% and a return on assets of -1.29%.
- Revenue is spread across five business segments, with the Dispensing Pharmacy segment being the primary source of operations.
- Growth is constrained by a net loss and limited free cash flow.
- Risk factors include a medium liquidity risk and a low dilution risk.
- --
- ## RATIONALES
- Net cash is negative after subtracting total debt.